Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

anti-HER2 molecule AIP-303

A molecule targeting the tumor-associated antigen (TAA) epidermal growth factor receptor 2 (HER2, EGFR2, ERBB2), with potential antineoplastic activity. Upon administration, the anti-HER2 molecule AIP-303 targets and binds to HER2-expressing cells. This may inhibit HER2-mediated signaling and inhibit growth in HER2-overexpressing tumor cells. HER2, a tyrosine kinase, is overexpressed on the cell surfaces of various tumor cell types.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Code name:	AIP 303 AIP-303 AIP303

anti-HER2 molecule AIP-303

Search NCI's Drug Dictionary